Expanding Non-Invasive Tests Yourgene's continuous launch of non-invasive prenatal testing solutions like IONA Care+ and IONA NIPT workflows indicates a growing market for maternal-fetal diagnostics. Opportunities exist to partner with healthcare providers and laboratories expanding NIPT services, especially in regions like Morocco where regional access is being enhanced.

Regional Market Development Recent installation of IONA NIPT workflows in new geographic locations demonstrates potential for business growth by offering customized prenatal diagnostic solutions in underserved markets. Focused outreach to hospitals and clinics in these areas could accelerate adoption and increase sales of Yourgene's genomic testing platforms.

Innovative Platform Offerings Yourgene's range of DNA sample preparation platforms powered by Ranger Technology positions the company as a key supplier for labs focused on liquid biopsy and oncology testing. Introducing these products to known diagnostic labs looking to expand their molecular testing capabilities represents a significant sales opportunity.

Strategic Collaborations Partnerships with charities and hospitals like Tommy’s and St Mary’s NHS highlight Yourgene's active engagement in research collaborations, which can pave the way to institutional contracts and customized service offerings for clinical research and large-scale diagnostic programs.

Growth in Molecular Diagnostics With a broad product portfolio in reproductive health, infectious diseases, and precision medicine, Yourgene offers multiple avenues for cross-selling to existing clients. Engaging pharmaceutical and research organizations supported by Yourgene's full lifecycle services presents further sales expansion potentials.